Article
Visual and refractive outcomes of the bioanalogic, polyfocal intraocular lens WIOL-CF after 3 months follow up (P)
Search Medline for
Authors
-
Erik Mertens
- Medipolis, Ophthalmplogy, Antwerpen, Belgien
| Published: | June 3, 2016 |
|---|
Outline
Text
Purpose: The purpose of this study was to assess the visual and refractive outcomes of the bioanalogic, polyfocal lens WIOL-CF after 3 months follow up.
Setting: Medipolis-Antwerp Private Clinic, Antwerp, Belgium
Methods: 30 eyes of 15 patients underwent implantation of bioanalogic, polyfocal WIOL-CF lens (MEDICEM Technology s.r.o., Czech Republic). All surgeries were performed by one surgeon using FSLACS procedure. The lens power calculation was based on Haigis formula. Main outcomes measures evaluated during a 3 months follow-up included: binocular and monocular uncorrected visual acuity (UCVA), refraction, best corrected visual acuity (BCVA), distance corrected visual acuity (DCVA) and questionnaire with optical phenomena and spectacle independence evaluations.
Results: The mean monocular logMAR results: UCDVA 0.07±0.09; UCIVA 0.01±0.05; UCNVA 0.06±0.05; BCDVA 0.02±0.04; BCNVA 0.04±0.05; DCNVA 0.06±0.05. The mean sphere –0.25±0.43 D (ranging from –1.50 to 0.00D). The mean binocular logMAR results: UCDVA 0.05±0.05; UCIVA 0.00±0.06; UCNVA 0.06±0.05. No adverse events were found during the follow-up period. All patients were spectacle free. No complaints of excessive halos or glare were reported (only one patient reported mild phenomena).
Conclusions: Bioanalogic, polyfocal IOL implantation after FSLACS was a safe and effective method for pseudophakic presbyopia correction in patients at all distances.
